P-wave duration and interatrial conduction abnormalities in paroxysmal and persistent typical atrial flutter
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
36073736
PubMed Central
PMC9841807
DOI
10.33549/physiolres.934731
PII: 934731
Knihovny.cz E-zdroje
- MeSH
- antiarytmika terapeutické užití MeSH
- elektrokardiografie MeSH
- fibrilace síní * MeSH
- flutter síní * diagnóza farmakoterapie epidemiologie MeSH
- lidé MeSH
- srdeční síně MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antiarytmika MeSH
Functional and structural changes, the enlargement of the right atrium is the background for the development of typical atrial flutter (AFL). These changes in ECG are manifested in the morphology of the initial part of the P-wave. The aim of the study was to assess the duration and morphology of the P-wave in patients with paroxysmal and persistent AFL. The study population consisted of 131 patients with AFL, 38 women and 93 men aged 66 years (60-72), divided in 62 patients with paroxysmal and 69 with persistent AFL. P-wave duration was measured with an electrophysiological system in all leads at a paper speed of 200 mm/s. The groups did differ in terms of gender (38/24 vs. 55/14, (M/F), p=0.033). Patients with persistent AF had a longer P-wave duration - 175±26.3 ms vs. 159±22.6 ms, p=0.01, and higher creatinine concentration - 1.2±0.60 mg/dl vs. 1.08±0.68 mg/dl, p=0.007. The presence and severity of interatrial conduction block (I-none, II-partial, III-total) was related to age of the patients (60.3±12.1 vs. 64.7±-8.3 vs. 68.9±9.5 years, respectively). Patients with persistent AFL show a longer P-wave compared to paroxysmal AFL, regardless of comorbidities and antiarrhythmic drugs. The arrhythmia-related longer P-wave duration should encourage the clinicians to restore sinus rhythm earlier in order to more effectively maintain it over the long term.
Zobrazit více v PubMed
Saoudi N, Cosío F, Waldo A, Chen SA, Iesaka Y, Lesh M, Saksena S, Salerno J, Schoels W Working Group of Arrhythmias of the European of Cardiology and the North American Society of Pacing and Electrophysiology. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases; a Statement from a Joint Expert Group from The Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 2020;22:1162–1182. doi: 10.1053/euhj.2001.2658. PubMed DOI
Allison JD, Macedo FY, Hamzeh IR, Birnbaum Y. Correlation of right atrial enlargement on ECG to right atrial volume by echocardiography in patients with pulmonary hypertension. J Electrocardiol. 2017;50:555–560. doi: 10.1016/j.jelectrocard.2017.04.012. PubMed DOI
Enriquez A, Santangeli P, Zado ES, Liang J, Castro S, Garcia FC, Schaller RD, et al. Postoperative atrial tachycardias after mitral valve surgery: Mechanisms and outcomes of catheter ablation. Heart Rhythm. 2017;14:520–526. doi: 10.1016/j.hrthm.2016.12.002. PubMed DOI
Waldo AL. Inter-relationships between atrial flutter and atrial fibrillation. Pacing Clin Electrophysiol. 2003;26:1583–1596. doi: 10.1046/j.1460-9592.2003.t01-1-00236.x. PubMed DOI
Cosío FG. Atrial flutter, typical and atypical: A review. Arrhythm Electrophysiol Rev. 2017;6:55–62. doi: 10.15420/aer.2017:5:2. PubMed DOI PMC
Sławuta A, Sokołowska M, Adamowicz J, Gajek J, Zysko D. Resolution of complete atrioventricular block after typical atrial flutter ablation. Folia Cardiologica. 2017;12:109–112. doi: 10.5603/FC.2017.0015. DOI
Calkins H, Canby R, Weiss R, Taylor G, Wells P, Chinitz L, Milstein S, Compton S, Oleson K, Sherfesee L, Onufer J 100W Atakr II Investigator Group. Results of catheter ablation of typical atrial flutter. Am J Cardiol. 2004;94:437–442. doi: 10.1016/j.amjcard.2004.04.058. PubMed DOI
Giehm-Reese M, Kronborg MB, Lukac P, Kristiansen SB, Nielsen JM, Johannessen A, Jacobsen PK, et al. Recurrent atrial flutter ablation and incidence of atrial fibrillation ablation after first-time ablation for typical atrial flutter: A nation-wide Danish cohort study. Int J Cardiol. 2020;298:44–51. doi: 10.1016/j.ijcard.2019.07.077. PubMed DOI
GULA LJ. Is atrial flutter ablation a stop along the road to atrial fibrillation? Int J Cardiol. 2020;298:52–53. doi: 10.1016/j.ijcard.2019.09.002. PubMed DOI
Unkell M, Marinov M, Wolff PS, Radziejewska J, Mercik JS, Gajek J. P wave duration in paroxysmal and persistent atrial fibrillation. Adv Clin Exp Med. 2020;29:1347–1354. doi: 10.17219/acem/127680. PubMed DOI
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2021;42:373–498. doi: 10.1093/eurheartj/ehaa612. PubMed DOI
Granada J, Uribe W, Chyou PH, Maassen K, Vierkant R, Smith PN, Hayes J, Eaker E, Vidaillet H. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol. 2000;36:2242–2246. doi: 10.1016/S0735-1097(00)00982-7. PubMed DOI
Lelorier P, Humphries KH, Krahn A, Connolly SJ, Talajic M, Green M, Sheldon R, et al. Prognostic differences between atrial fibrillation and atrial flutter. Am J Cardiol. 2004;93:647–649. doi: 10.1016/j.amjcard.2003.11.042. PubMed DOI
Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH, Dimitri H, Wilson L, Young GD, Sanders P. Characterization of atrial remodeling studied remote from episodes of typical atrial flutter. Am J Cardiol. 2010;106:528–534. doi: 10.1016/j.amjcard.2010.03.069. PubMed DOI
Mercik J, Gajek A, Radziejewska J, Sławuta A, Gajek J, Kozłowski D. The short P-wave - Is it really short? Cardiol J. 2021;28:999–1000. doi: 10.5603/CJ.2021.0160. PubMed DOI PMC
Bayés De Luna A, Cladellas M, Oter R, Torner P, Guindo J, Martí V, Rivera I, Iturralde P. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J. 1988;9:1112–1118. doi: 10.1093/oxfordjournals.eurheartj.a062407. PubMed DOI
Irie T, Kaneko Y, Nakajima T, Saito A, Ota M, Kato T, Iijima T, et al. Typical atrial flutter with atypical flutter wave morphology due to abnormal interatrial conduction. Cardiol J. 2011;18:450–453. PubMed
Zawadzki JM, Zimmer K, Przywara W, Zyśko D, Radziejewska J, Sławuta A, Gajek J. The true nature of P wave dispersion. Adv Clin Exp Med. 2020;29:1443–1447. doi: 10.17219/acem/128232. PubMed DOI
Wang A, Green JB, Halperin JL, Piccini JP. Atrial fibrillation and diabetes mellitus. J Am Coll Cardiol. 2019;74:1107–1115. doi: 10.1016/j.jacc.2019.07.020. PubMed DOI
Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005;105:315–317. doi: 10.1016/j.ijcard.2005.02.050. PubMed DOI
Fu H, Liu C, Li J, Zhou C, Cheng L, Liu T, Li G. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiol J. 2013;20:59–67. doi: 10.5603/CJ.2013.0010. PubMed DOI
Li B, Pan Y, Li X. Type 2 diabetes induces prolonged P-wave duration without left atrial enlargement. J Korean Med Sci. 2016;31:525–534. doi: 10.3346/jkms.2016.31.4.525. PubMed DOI PMC
Ayhan S, Ozturk S, Alcelik A, Ozlu MF, Erdem A, Memioglu T, Ozdemir M, Yazici M. Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose. J Interv Card Electrophysiol. 2012;35:247–252. doi: 10.1007/s10840-012-9722-1. PubMed DOI
Huang JC, Wei SY, Chen SC, Chang JM, Hung CC, Su HM, Hwang SJ, Chen HC. P wave dispersion and maximum P wave duration are associated with renal outcomes in chronic kidney disease. PLoS One. 2014;9:e101962. doi: 10.1371/journal.pone.0101962. PubMed DOI PMC
Su HM, Tsai WC, Lin TH, Hsu PC, Lee WH, Lin MY, Chen SC, Lee CS, Voon WC, Lai WT, Sheu SH. P wave dispersion and maximum P wave duration are independently associated with rapid renal function decline. PLoS One. 2012;7:e42815. doi: 10.1371/journal.pone.0042815. PubMed DOI PMC
Wenger NK, Stein PD, Willis PW., 3rd Massive acute pulmonary embolism. The deceivingly nonspecific manifestations. JAMA. 1972;220:843–844. doi: 10.1001/jama.1972.03200060067013. PubMed DOI
Ullman E, Brady WJ, Perron AD, Chan T, Mattu A. Electrocardiographic manifestations of pulmonary embolism. Am J Emerg Med. 2001;19:514–519. doi: 10.1053/ajem.2001.27172. PubMed DOI
Celikyurt U, Knecht S, Kuehne M, Reichlin T, Muehl A, Spies F, Osswald S, Sticherling C. Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for atrial flutter. Europace. 2017;19:1776–1780. doi: 10.1093/europace/euw343. PubMed DOI
Lee YS, Hyun DW, Jung BC, Cho YK, Lee SH, Shin DG, Park HS, Han SW, Kim YN KTK Cardiac Electrophysiology Working Group. Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter. J Cardiol. 2010;56:348–353. doi: 10.1016/j.jjcc.2010.07.006. PubMed DOI
Ozcan C, Strom JB, Newell JB, Mansour MC, Ruskin JN. Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias. Europace. 2014;16:1508–1514. doi: 10.1093/europace/euu129. PubMed DOI
Enriquez A, Sarrias A, Villuendas R, Ali FS, Conde D, Hopman WM, Redfearn DP, Michael K, Simpson C, De Luna AB, Bayés-Genís A, Baranchuk A. New-onset atrial fibrillation after cavotricuspid isthmus ablation: identification of advanced interatrial block is key. Europace. 2015;17:1289–1293. doi: 10.1093/europace/euu379. PubMed DOI